At 24 mg, the majority of participants achieved clinically meaningful weight loss thresholds, and by week 48, 95.7% of individuals treated with CT-388 lost a minimum of 5% of body weight, while 87% achieved reductions of at least 10%
Dont worry yet my surgical friends, but more effective peptide-based medicines are on the way #endocrinologyrocks The Lancet @TheLancet Aug 16, 2018 In #obese individuals without #diabetes, #semaglutide, with diet & exercise, resulted in significantly greater #weightloss over 52 weeks than placebo and liraglutidefindings from a phase 2, RCT #obesity hubs.ly/H0dqCsT0 Daniel J Drucker @DanielJDrucker Aug 17, 2018 Changing the conversation in the office between HCP and PPL #Obesity Rxment options
However, significant concerns exist regarding reducing lean mass, particularly in studies involving a larger patient population
Forcing water directly onto the powder creates foam and can damage the peptide structure